Purpose This guideline provides updated evidence-based recommendations addressing
recent developments in the management of patients with brain metastases, including …

However, the number of randomized clinical trials performed to evaluate the therapeutic
options for brain metastases is still limited, leaving evidence-based management of this …

Treating brain tumors requires a nuanced understanding of the brain, a vital and delicate
organ. Location, size, tumor type, and surrounding tissue health are crucial in develo** …

Purpose To investigate the local control and radiation-induced brain necrosis in patients
with brain metastases> 2 cm in size who received single-fraction or multifraction stereotactic …

Stereotactic radiosurgery (SRS), typically administered in a single session, is widely
employed to safely, efficiently, and effectively treat small intracranial lesions. However, for …

OBJECTIVE Stereotactic radiosurgery (SRS) is the primary modality for treating brain
metastases. However, effective radiosurgical control of brain metastases≥ 2 cm in …

Stereotactic radiosurgery (SRS) delivered in 2–5 fractions (multi-fraction SRS) has been
employed in patients with brain metastases as an alternative to single-fraction SRS with the …

Background: While the role of stereotactic radiotherapy for brain metastases is increasing,
evidence on the comparative efficacy and safety of fractionated stereotactic radiotherapy …

Abstract Background Hypofractionated-SRS (HF-SRS) may allow for improved local control
and a reduced risk of radiation necrosis compared to single-fraction-SRS (SF-SRS) …

Simple Summary Brain metastases are one of the most frequent complications for cancer
patients. Stereotactic radiosurgery is considered a cornerstone treatment for patients with …